Utah State researchers have identified new CRISPR-Cas12a3 functions that selectively target pathogen RNA without harming host DNA, potentially enabling a single diagnostic test for COVID-19, flu, and RSVV..
A University of Warwick study finds AI cancer detection models may rely on statistical correlations rather than true biomarker signals, raising concerns about reliability in clinical pathology applications.
Johns Hopkins researchers have developed an AI-driven liquid biopsy that uses cell-free DNA fragmentation patterns to detect early liver fibrosis and cirrhosis, according to a study in Science Translational Medicine.
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
Thermo Fisher Scientific has opened an $18 million, 8,000-square-meter distribution and labeling center in Uppsala, Sweden, to support global supply of immunodiagnostics for allergy and autoimmune disease testing.
